Global Pacemaker Market Research Report: Information by Implantability (Implantable Pacemakers and External Pacemaker), Technology (Dual-Chamber Pacemakers, Single-Chamber Pacemakers and Biventricular/CRT Pacemakers), Type (MRI Compatible Pacemakers and Conventional Pacemakers), End User (Hospitals & Cardiac Centers and Ambulatory Surgical Centers) and Region (Americas, Europe, Asia-Pacific and Middle East & Africa) - Forecast till 2027
ID: MRFR/MED/1058-HCR | February 2021 | Region: Global | 90 pages
Market Scenario
Pacemaker Market is projected to reach USD 4.2 Billion in 2018 and expected to register a 2.5% CAGR during the forecast period. The pacemaker is a small device implanted in the chest to regulate abnormal heart rhythm. Pacemakers are used in medical conditions such as arrhythmia, atrial fibrillation, heart block, and long QT syndrome. The primary factors driving the growth of global pacemaker market are rising incidences of cardiovascular disorders, technological advancements in pacemakers, and increasing research and development for pacemakers.
According to the American Heart Association, cardiovascular disorders (CVD) is the leading cause of death globally, accounting for more than 17.6 million deaths per year in 2016. Additionally, the rising healthcare expenditure for cardiovascular disorders is driving market growth. For instance, according to the American Heart Association, CVD and stroke accounted for 14% of total health expenditures in 2016. This rise in cardiovascular cases and rising healthcare expenditure is expected to drive the market growth.
However, the high cost of pacemakers and unfavorable reimbursement scenarios may hinder the market growth during the forecasted period.
Segmentation
Global Pacemaker Market has been segmented into implantability, technology, type, and end users.
By implantability, the global market has been divided into implantable pacemakers and external pacemakers.
On the basis of technology, the global market has been segmented into dual-chamber pacemakers, single-chamber pacemakers, and biventricular/CRT pacemakers.
Based on type, the global market has been bifurcated into MRI compatible pacemakers and conventional pacemakers.
On the basis of end user, the global market has been divided into hospitals & cardiac centers and ambulatory surgical centers.
The market has been segmented, by region, into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The pacemaker market in the Americas has further been segmented into North America and Latin America, with the North American market divided into the US and Canada.
The European pacemaker market has been segmented into Western Europe and Eastern Europe. Western Europe has further been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.
The pacemaker market in Asia-Pacific has been segmented into Japan, China, India, Latin Korea, Australia, and the rest of Asia-Pacific. The pacemaker market in the Middle East & Africa has been segmented into the Middle East and Africa.
Key Players
Medtronic (Dublin, Ireland), Abbott Laboratories (US), Boston Scientific (US), Biotronik (Germany), Livanova (UK), Lepu Medical (China), Shree Pacetronix (India), Osypka Medical (Germany), Medico Spa (Italy), and Oscor (US) are some of the key players operating in the global pacemaker market.
Regional Market Summary
Global Pacemaker Market Share (%), by Region, 2018 
Source: Centers for Disease Control and Prevention (CDC), Eurostat, White Papers, Company Presentations, Annual Reports
Geographically, the market has been segmented into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. The Americas dominated the pacemaker market owing to the increasing prevalence of cardiovascular disorders, growing geriatric population, and rapid technological advancements. According to the Centers for Disease Control and Prevention, every year about 735,000 Americans have a heart attack. Additionally, the American Heart Association stated that by 2035 more than 130 million adults or 45.1% of the US population are expected to have some form of CVD in their lifetime.
Europe is expected to be the second-largest region in the pacemaker market owing to the increasing health problems such as hypertension, stress, obesity, and changing lifestyles. Additionally, the increasing cases of CVD and rising initiatives to create awareness is driving the growth of the pacemaker market in the region. For instance, the European Commission and the European Heart Network (EHN) established the European Heart Health Initiative (EHHI) to prevent cardiovascular diseases (CVDs). Such initiatives promote to drive the growth of the pacemaker market in Europe.
Asia-Pacific was anticipated to be the fastest-growing region in the pacemaker market. The market in the region is expected to witness growth owing to the increasing population and rising demand for technologically advanced products. The prevalence of CVD is high in developing countries and cities, such as Japan, Hong Kong, and Singapore, which support market growth.
The market in the Middle East & Africa holds a low share in the pacemaker market due to the presence of a low number of healthcare facilities, low per capita income, and limited awareness of upcoming treatment methods in underdeveloped countries. However, the market is expected to witness growth due to increasing hospitals and rising demand for pacemakers in the Middle East.
Global Pacemaker Market, by Implantability
- Implantable Pacemakers
- External Pacemaker
Global Pacemaker Market, by Technology
- Dual-Chamber Pacemakers
- Single-Chamber Pacemakers
- Biventricular/CRT Pacemakers
Global Pacemaker Market, by Type
- MRI Compatible Pacemakers
- Conventional Pacemakers
Global Pacemaker Market, by End User
- Hospitals & Cardiac Centers
- Ambulatory Surgical Centers
Global Pacemaker Market, by Region
- Americas
- North America
- US
- Canada
- Latin America
- North America
- Europe
- Western Europe
- Germany
- France
- Italy
- Spain
- UK
- Rest of Western Europe
- Eastern Europe
- Western Europe
- Asia-Pacific
- Japan
- China
- India
- Australia
- Latin Korea
- Rest of Asia-Pacific
- Middle East & Africa
- Middle East
- Africa
Intended Audience
- Cardiovascular disorders treatment centers
- Contract research organizations (CROs)
- Research and development (R&D) companies
- Government research laboratories
- Independent research laboratories
- Government and independent regulatory authorities
- Market research and consulting service providers
- Medical research laboratories
- Academic medical institutes and universities
Report Scope:
| Report Attribute/Metric | Details |
|---|---|
| Market Size | USD 4.2 Billion (2018) |
| CAGR | 2.5% (2020 - 2025) |
| Base Year | 2019 |
| Forecast Period | 2020-2027 |
| Historical Data | 2018 |
| Forecast Units | Value (USD Million) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | by Implantability, Technology, End User |
| Geographies Covered | North America, Europe, Asia-Pacific, and Rest of the World (RoW) |
| Key Vendors | Medtronic (Dublin, Ireland), Abbott Laboratories (US), Boston Scientific (US), Biotronik (Germany), Livanova (UK), Lepu Medical (China), Shree Pacetronix (India), Osypka Medical (Germany), Medico Spa (Italy), and Oscor (US) |
| Key Market Opportunities |
|
| Key Market Drivers | The high cost of pacemakers and unfavorable reimbursement scenarios may hinder the market growth during the forecasted period. |
Frequently Asked Questions (FAQ) :
The valuation of the global pacemaker market had reached USD 4.2 BN in 2018.
pacemaker market is projected to grow at approximately 2.5% CAGR during the assessment period (2019-2025).
Rising incidences of cardiovascular disorders, technological advances in pacemakers, and increasing R&D expenses for pacemakers are the major tailwinds pushing the growth of the global pacemaker market.
North America holds the largest share in the global pacemaker market, followed by Europe and the Asia Pacific, respectively.
Biotronik GmbH & Co. KG (Germany), ATS Medical (US), Boston Scientific Corporation (US), Medtronic Plc (US), Edwards Lifesciences (US), Sorin Group, St. Jude Medical Inc. (US), Zoll Medical Corporation (US), and Vitatron Holding B.V. (the Netherlands), are some of the major players operating in the pacemaker market.
Table of Content
Chapter 1. Report Prologue
Chapter 2. Market Introduction
2.1 Definition
2.2 Scope of the Study
2.2.1 Research Objective
2.2.2 Assumptions
2.2.3 Limitations
Chapter 3. Research Methodology
3.1 Introduction
3.2 Primary Research
3.3 Secondary research
3.4 Market Size Estimation
Chapter 4. Market Dynamics
4.1 Drivers
4.2 Restrains
4.3 Opportunities
4.4 Challenges
Chapter 5. Market Factor Analysis
5.1 Porters Five Forces Analysis
5.1.1 Bargaining Power of Suppliers
5.1.2 Bargaining Power of Buyers
5.1.3 Threat of New Entrants
5.1.4 Threat of Substitutes
5.1.5 Intensity of Rivalry
5.2 Value Chain Analysis
Chapter 6. Global Pacemaker Market, by Implantability
6.1 Introduction
6.2 Implantable Pacemakers
6.3 External Pacemaker
Chapter 7. Global Pacemaker Market, by Technology
7.1 Introduction
7.2 Dual-Chamber Pacemakers
7.3 Single-Chamber Pacemakers
7.4 Biventricular/CRT Pacemakers
Chapter 8. Global Bipolar Disorders and Treatment Market, by Type
8.1 Introduction
8.2 MRI Compatible Pacemakers
9.3 Conventional Pacemakers
Chapter 8. Global Bipolar Disorders and Treatment Market, by End User
8.1 Introduction
8.2 Hospitals & Cardiac Centers
9.3 Ambulatory Surgical Centers
Chapter 9. Global Pacemaker Market, by Region
9.1 Introduction
9.2 America
9.2.1 North America
9.2.1.1 US
9.2.1.2 Canada
9.2.2 Latin America
9.3 Europe
9.3.1 Western Europe
9.3.1.1 Germany
9.3.1.2 France
9.3.1.3 Italy
9.3.1.4 Spain
9.3.1.5 UK
9.3.1.6 Rest of Western Europe
9.3.2 Eastern Europe
9.4 Asia-Pacific
9.4.1 Japan
9.4.2 China
9.4.3 India
9.4.4 Australia
9.4.5 Republic of Korea
9.4.6 Rest of Asia-Pacific
9.5 Middle East & Africa
9.5.1 Middle East
9.5.2 Africa
Chapter 10. Company Landscape
10.1 Introduction
10.2 Market Share Analysis
10.3 Key Development & Strategies
Chapter 11 Company Profiles
11.1 Medtronic
11.1.1 Company Overview
11.1.2 Type Overview
11.1.3 Financial Overview
11.1.4 Key Developments
11.1.5 SWOT Analysis
11.2 Abbott Laboratories
11.2.1 Company Overview
11.2.2 Type Overview
11.2.3 Financial Overview
11.2.4 Key Developments
11.2.5 SWOT Analysis
11.3 Boston Scientific
11.3.1 Company Overview
11.3.2 Type Overview
11.3.3 Financial Overview
11.3.4 Key Development
11.3.5 SWOT Analysis
11.4 Biotronik
11.4.1 Company Overview
11.4.2 Segment Overview
11.4.3 Financial Overview
11.4.4 Key Development
11.4.5 SWOT Analysis
11.5 Livanova
11.5.1 Company Overview
11.5.2 Type Overview
11.5.3 Financial overview
11.5.4 Key Developments
11.5.5 SWOT Analysis
11.6 Lepu Medical
11.6.1 Company Overview
11.6.2 Type Overview
11.6.3 Financial Overview
11.6.4 Key Developments
11.6.5 SWOT Analysis
11.7 Shree Pacetronix
11.7.1 Overview
11.7.2 Type Overview
11.7.3 Financial Overview
11.7.4 Key Developments
11.7.5 SWOT Analysis
11.8 Osypka Medical
11.8.1 Overview
11.8.2 Type Overview
11.8.3 Financial Overview
11.8.4 Key Developments
11.8.5 SWOT Analysis
11.9 Medico Spa
11.9.1 Overview
11.9.2 Type Overview
11.9.3 Financial Overview
11.9.4 Key Developments
11.9.5 SWOT Analysis
11.10 Oscor
11.10.1 Overview
11.10.2 Type Overview
11.10.3 Financial Overview
11.10.4 Key Developments
11.10.5 SWOT Analysis
11.11 Others
Chapter 12. Appendix
LIST OF TABLES
Table 1 Global Pacemaker Synopsis, 2020-2027
Table 2 Global Pacemaker Market Estimates and Forecast, 2020-2027, (USD Million)
Table 3 Global Pacemaker Market, by Region 2020-2027, (USD Million)
Table 4 Global Pacemaker Market, by Implantability 2020-2027, (USD Million)
Table 5 Global Pacemaker Market, by Technology 2020-2027, (USD Million)
Table 5 Global Pacemaker Market, by Type 2020-2027, (USD Million)
Table 6 Global Pacemaker Market, by End User 2020-2027, (USD Million)
Table 7 North America: Pacemaker Market, by Implantability 2020-2027, (USD Million)
Table 8 North America: Pacemaker Market, by Technology 2020-2027, (USD Million)
Table 8 North America: Pacemaker Market, by Type 2020-2027, (USD Million)
Table 9 North America: Pacemaker Market, by End User 2020-2027, (USD Million)
Table 10 US: Pacemaker Market, by Implantability 2020-2027, (USD Million)
Table 11 US: Pacemaker Market, by Technology 2020-2027, (USD Million)
Table 8 US: Pacemaker Market, by Type 2020-2027, (USD Million)
Table 12 US: Pacemaker Market, by End User 2020-2027, (USD Million)
Table 13 Canada: Pacemaker Market, by Implantability 2020-2027, (USD Million)
Table 14 Canada: Pacemaker Market, by Technology 2020-2027, (USD Million)
Table 8 Canada: Pacemaker Market, by Type 2020-2027, (USD Million)
Table 15 Canada: Pacemaker Market, by End User 2020-2027, (USD Million)
Table 16 Latin America: Pacemaker Market, by Implantability 2020-2027, (USD Million)
Table 17 Latin America: Pacemaker Market, by Technology 2020-2027, (USD Million)
Table 8 Latin America: Pacemaker Market, by Type 2020-2027, (USD Million)
Table 18 Latin America: Pacemaker Market, by End User 2020-2027, (USD Million)
Table 19 Europe: Pacemaker Market, by Implantability 2020-2027, (USD Million)
Table 20 Europe: Pacemaker Market, by Technology 2020-2027, (USD Million)
Table 8 Europe: Pacemaker Market, by Type 2020-2027, (USD Million)
Table 21 Europe: Pacemaker Market, by End User 2020-2027, (USD Million)
Table 22 Western Europe: Pacemaker Market, by Implantability 2020-2027, (USD Million)
Table 23 Western Europe: Pacemaker Market, by Technology 2020-2027, (USD Million)
Table 8 Western Europe: Pacemaker Market, by Type 2020-2027, (USD Million)
Table 24 Western Europe: Pacemaker Market, by End User 2020-2027, (USD Million)
Table 25 Eastern Europe: Pacemaker Market, by Implantability 2020-2027, (USD Million)
Table 26 Eastern Europe: Pacemaker Market, by Technology 2020-2027, (USD Million)
Table 8 Eastern Europe: Pacemaker Market, by Type 2020-2027, (USD Million)
Table 27 Eastern Europe: Pacemaker Market, by End User 2020-2027, (USD Million)
Table 28 Asia-Pacific: Pacemaker Market, by Implantability 2020-2027, (USD Million)
Table 29 Asia-Pacific: Pacemaker Market, by Technology 2020-2027, (USD Million)
Table 8 Asia-Pacific: Pacemaker Market, by Type 2020-2027, (USD Million)
Table 30 Asia-Pacific: Pacemaker Market, by End User 2020-2027, (USD Million)
Table 31 Middle East & Africa: Pacemaker Market, by Implantability 2020-2027, (USD Million)
Table 32 Middle East & Africa: Pacemaker Market, by Technology 2020-2027, (USD Million)
Table 8 Middle East & Africa: Pacemaker Market, by Type 2020-2027, (USD Million)
Table 33 Middle East & Africa: Pacemaker Market, by End User 2020-2027, (USD Million)
LIST OF FIGURES
Figure 1 Research Process
Figure 2 Segmentation of the Global Pacemaker Market
Figure 3 Market Dynamics of the Global Pacemaker Market
Figure 4 Global Pacemaker Market Share, by Implantability, 2020
Figure 5 Global Pacemaker Market Share, by Technology, 2020
Figure 6 Global Pacemaker Market Share, by Type, 2020
Figure 7 Global Pacemaker Market Share, by End User, 2020
Figure 8 Global Pacemaker Market Share, by Region, 2020
Figure 9 North America: Pacemaker Market Share, by Country, 2020
Figure 10 Europe: Pacemaker Market Share, by Country, 2020
Figure 11 Asia-Pacific: Pacemaker Market Share, by Country, 2020
Figure 12 Middle East & Africa: Pacemaker Market Share, by Country, 2020
Figure 13 Global Pacemaker Market: Company Share Analysis, 2020 (%)
Figure 14 Medtronic plc: Key Financials
Figure 15 Medtronic plc: Segmental Revenue
Figure 16 Medtronic plc: Regional Revenue
Figure 17 Abbott Laboratories: Key Financials
Figure 18 Abbott Laboratories: Segmental Revenue
Figure 19 Abbott Laboratories: Regional Revenue
Figure 20 Boston Scientific: Key Financials
Figure 21 Boston Scientific.: Segmental Revenue
Figure 22 Boston Scientific: Regional Revenue
Figure 23 Biotronik: Key Financials
Figure 24 Biotronik: Segmental Revenue
Figure 25 Biotronik: Regional Revenue
Figure 26 Livanova: Key Financials
Figure 27 Livanova: Segmental Revenue
Figure 28 Livanova: Regional Revenue
Figure 29 Lepu Medical: Key Financials
Figure 30 Lepu Medical: Segmental Revenue
Figure 31 Lepu Medical: Regional Revenue
Figure 32 Osypka Medical: Key Financials
Figure 33 Osypka Medical: Segmental Revenue
Figure 34 Osypka Medical: Regional Revenue
Figure 35 Oscor: Key Financials
Figure 36 Oscor: Segmental Revenue
Figure 37 Oscor: Regional Revenue
Figure 38 Medico Spa: Key Financials
Figure 39 Medico Spa: Segmental Revenue
Figure 40 Medico Spa: Regional Revenue
Figure 41 Shree Pacetronix: Key Financials
Figure 42 Shree Pacetronix: Segmental Revenue
Figure 43 Shree Pacetronix: Regional Revenue
